Thyroid Hormone Values and Anti-thyroid Peroxidase Antibody Positivity in Recurrent Pregnancy Loss

Sponsor
Zonguldak Bulent Ecevit University (Other)
Overall Status
Completed
CT.gov ID
NCT05680376
Collaborator
(none)
103
1
57
1.8

Study Details

Study Description

Brief Summary

The aim of this study is to compare the thyroid hormone values and anti-thyroid peroxidase (anti-TPO) levels of women with a diagnosis of recurrent pregnancy loss (RPL) and healthy pregnancies. The primary objective is to find out the relationship between recurrent pregnancy loss with thyroid hormone levels and anti-TPO positivity.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    103 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Relationship Between Habitual Abortion With Thyroid Hormone Values and Anti-TPO (Anti-thyroid Peroxidase Antibody) Positivity
    Actual Study Start Date :
    Jan 1, 2018
    Actual Primary Completion Date :
    Oct 1, 2022
    Actual Study Completion Date :
    Oct 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Recurrent Pregnancy loss

    patients with a diagnosis of recurrent miscarriage

    Healthy Controls

    healthy women at same age and similar demographics

    Outcome Measures

    Primary Outcome Measures

    1. Anti-thyroid Peroxidase Antibodies [4 years]

      presence of Anti-thyroid Peroxidase Antibodies in both groups

    2. Thyroid Hormone Levels [4 years]

      levels of Thyroid stimulant Hormone, Thyroxin and triiodothyronine levels

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • women with 2 or more pregnancy loses

    • for controls women with least one healthy baby

    Exclusion Criteria:
    • any other metabolic disease

    • women with one miscarriage

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zonguldak Bulent Ecevit University Faculty of Medicine Zonguldak Turkey

    Sponsors and Collaborators

    • Zonguldak Bulent Ecevit University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Büşra Özgen Çeviker, Resident at Family Medicine Department, Zonguldak Bulent Ecevit University
    ClinicalTrials.gov Identifier:
    NCT05680376
    Other Study ID Numbers:
    • 2022/17
    First Posted:
    Jan 11, 2023
    Last Update Posted:
    Jan 11, 2023
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Büşra Özgen Çeviker, Resident at Family Medicine Department, Zonguldak Bulent Ecevit University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 11, 2023